HOME - AF-ABLATION

The clinical and research activity of Prof. Pappone’s team, made up of about 90 professionals, is dedicated to the development and implementation of new therapeutic strategies in patients with atrial fibrillation and flutter, WPW syndrome, nodal and atrioventricular reciprocating tachycardia, ventricular tachycardias, ventricular extrasystole, auricle occlusion, and implantation of cardiac stimulation devices and defibrillators. We are the leading center in the world for the practice of ablative therapy and the study of the omics of Brugada syndrome, long QT syndrome, and other genetic heart diseases. Particular interest is addressed to arrhythmogenic dysplasia, hypertrophic cardiomyopathy, noncompaction cardiomyopathy, and dilated cardiomyopathy.

FIND OUT MORE

The department has three operating rooms, one of which is a hybrid room, equipped with all the most advanced robotic navigation systems for the intracavitary ablation procedures of cardiac arrhythmias and for the implantation of cardiac stimulation devices. The department has 45 hospitalization beds, all equipped with electrocardiographic and telemetric continuous monitoring with 12 leads, and outpatient facilities where all diagnostic procedures are performed for the identification and treatment of cardiac arrhythmias, including a cardiogenetic service and a remote monitoring service, from which over 3500 patients with implantable cardiac devices are followed. In the research laboratories, the molecular and functional mechanisms of cardiac arrhythmias are studied.

FIND OUT MORE

Carlo Pappone – Does the clock of life exist? Exploring the heart you can discover – Science Philosophy Festival – Foligno (PG) Published May 31, 2019

SEE VIDEO – INTERVIEWS